Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Universal Biosensors Inc.
UBICurrent price
0.13 AUD
0 AUD (0.00%)
Last closed
0.13 AUD
Company
www.universalbiosensors.com
ISIN
AU000000UBI2
Sector
Healthcare
Industry
Medical Devices
Exchange
Australian Securities Exchange
Capitalization
37 383 604 AUD
Yield for 12 month
-35.90 %
1Y
3Y
5Y
10Y
15Y
UBI
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices used in healthcare (point-of-care), wine, food, and agriculture industries in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of the anticoagulant therapy warfarin; and Sentia wine testing products, such as free SO2, malic acid, glucose, fructose, total acid, and titratable acidity. It also offers non-diagnostic laboratory services and performs coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a test strip and a meter to be used for the detection and monitoring of diabetes in non-humans. Universal Biosensors, Inc. was incorporated in 2001 and is based in Rowville, Australia. Address: 1 Corporate Avenue, Rowville, VIC, Australia, 3178
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.56 AUDP/E ratio
–Dividend Yield
–Current Year
+6 655 132 AUD
Last Year
+4 540 171 AUD
Current Quarter
+1 631 029 AUD
Last Quarter
+1 474 449 AUD
Current Year
+3 331 063 AUD
Last Year
+2 146 221 AUD
Current Quarter
+928 310 AUD
Last Quarter
+626 868 AUD
Key Figures UBI
1 year
3 years
5 years
10 years
EBITDA
-15 271 030 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-32.72 %
PEG Ratio
–
Return On Equity TTM
-58.81 %
Wall Street Target Price
0.56 AUD
Revenue TTM
7 104 150 AUD
Book Value
0.07 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-2.5 %
Dividend Yield
–
Gross Profit TTM
2 146 220 AUD
Earnings per share
-0.05 AUD
Diluted Eps TTM
-0.05 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-175.04 %
Dividend Analytics UBI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History UBI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation UBI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
4.2062
Price Sales TTM
5.4727
Enterprise Value EBITDA
-7.1305
Price Book MRQ
1.8536
Financials UBI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators UBI
For 52 weeks
0.12 AUD
0.3 AUD
50 Day MA
0.14 AUD
Shares Short Prior Month
–
200 Day MA
0.15 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart